Genetic Technologies Ltd representing 150 ordinary shares (GENE): Price and Financial Metrics
Genetic Technologies Ltd representing 150 ordinary shares (GENE)
Today's Latest Price: $2.41 USD
0.09 (3.88%)
Updated Jul 2 4:00pm
Add GENE to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 58 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
GENE Stock Summary
- For GENE, its debt to operating expenses ratio is greater than that reported by merely 0.34% of US equities we're observing.
- GENE's price/sales ratio is 26,106.87; that's higher than the P/S ratio of 99.96% of US stocks.
- Revenue growth over the past 12 months for Genetic Technologies Ltd comes in at -99.21%, a number that bests only 0.54% of the US stocks we're tracking.
- Stocks with similar financial metrics, market capitalization, and price volatility to Genetic Technologies Ltd are IMMU, CYAD, ADVM, NK, and URGN.
- GENE's SEC filings can be seen here. And to visit Genetic Technologies Ltd's official web site, go to www.gtglabs.com.
GENE Daily Price Range
GENE 52-Week Price Range
GENE Stock Price Chart Technical Analysis Charts
GENE Price/Volume Stats
| Current price | $2.41 | 52-week high | $5.36 |
| Prev. close | $2.32 | 52-week low | $1.41 |
| Day low | $2.18 | Volume | 1,129,383 |
| Day high | $2.45 | Avg. volume | 1,026,269 |
| 50-day MA | $2.15 | Dividend yield | N/A |
| 200-day MA | $2.37 | Market Cap | 20.54M |
Loading social stream, please wait...